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Introduction
Primary aldosteronism (PA) is a major secondary 
cause of elevated blood pressure, with an recently 
estimated prevalence of 16–22% among the hyper-
tensive population [1]. Importantly, it generates more 
detrimental cardiovascular, renal, and metabolic 
outcomes than equally severe essential hypertension 
[2–5]. Fortunately, targeted treatment is possible. If 
lateralized disease is reliably demonstrated, the thera-
peutic method of choice is unilateral laparoscopic 
adrenalectomy, which normalizes blood pressure 
in approximately 40% of patients and significantly 
alleviates hypertension in others, thereby reducing 
the risk of chronic complications [6, 7]. Other patients 
with PA are treated with mineralocorticoid receptor 
antagonists and dietary sodium restriction, which is 
a less favourable and more expensive option in the 
long run than surgery [4, 8, 9].
Currently, adrenal vein sampling (AVS) is the pre-
ferred method to select the right patients with PA for 
the operation, because the use of adrenal imaging alone 
can frequently lead to PA subtype misclassification and 
significantly lower cure rates [7, 10]. Unfortunately, 
AVS is not widely available, being an invasive, costly, 
and a technically difficult procedure with successful 
bilateral catheterization obtained in only about 75% of 
cases on average [11, 12]. The cannulation of the left 
adrenal vein (LAV) is often relatively uncomplicated; 
however, sampling from the small and short right ad-
renal vein (RAV), which drains straight into the inferior 
vena cava (IVC), is much more difficult and might be 
the main reason for a failed procedure [13–15]. Thus, in 
some patients, the investigation needs to be repeated, 
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Abstract 
Introduction: Failure of adrenal vein sampling (AVS) due to difficult cannulation of the right adrenal vein (AV) frequently precludes sub-
typing of patients with primary aldosteronism (PA) before adrenalectomy. According to a recent study, lateralized PA could be accurately 
predicted from partial AVS data based on the gradient of the aldosterone-to-cortisol ratios (ACR) between left AV and inferior vena cava 
(IVC) (LAV/IVC index). We aimed to validate the diagnostic utility of this index for PA subtyping in our cohort.
Material and methods: A retrospective cross-sectional study included all patients who underwent bilaterally successful AVS at our centre 
and were diagnosed with either bilateral PA according to AVS or with lateralized PA after successful adrenalectomy from November 2004 
to the end of 2019. Final diagnoses were compared to originally suggested LAV/IVC index cut-offs of ≥ 5.5 for ipsilateral disease and of 
≤ 0.5 for contralateral disease, respectively. 
Results: The inclusion criteria were met in 168 patients: 46 women and 122 men, aged 54 years on average (range 32–72 years); 67 with 
lateralized and 101 with bilateral PA. LAV/IVC index using cut-offs of ≥ 5.5 or ≤ 0.5 anticipated ipsilateral (left lateralized) PA with a sen-
sitivity of 32% and specificity of 97%, while a sensitivity of 47% and specificity of 95%, were found for contralateral (right lateralized) PA 
in our cohort. The overall inappropriate adrenalectomy rate was 29.7% (p = 0.314 for comparison between sides). When ascertaining 
ipsilateral disease (LAV/IVC index ≥ 5.5), 4 out of 16 patients (25%) would have been incorrectly sent to left adrenalectomy. Inappropriate 
right adrenalectomy would have occurred in 7 out of 21 patients (33.3%) when predicting contralateral disease (LAV/IVC index of ≤ 0.5). 
Thus, 11 patients with bilateral PA (6.5% of the entire cohort) would have been misclassified as lateralized PA and referred to surgery. Failed 
lateralization would have occurred in 61.2% of patients overall (53.3% for overlooked contralateral disease, 67.6% for missed ipsilateral 
disease; p = 0.723 for comparison between sides).
Conclusions: Based on our cohort, we conclude that application of the suggested LAV/IVC index cut-offs did not predict lateralized PA 
with the high accuracy previously reported. (Endokrynol Pol 2021; 72 (4): 293–300)
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ratio [14, 15, 25]. Lateralized PA was diagnosed in patients who 
had successful AVS with an LI of more than 4 [25] and subsequent 
unilateral adrenalectomy with confirmed complete biochemical 
cure according to PASO criteria 6–12 months after the operation [6]. 
Bilateral PA was diagnosed in the context of bilaterally successful 
adrenal vein cannulation and LI below 3. Patients with equivocal 
LI values between 3 and 4 were excluded from the analysis [15, 25]. 
Figure 1 shows a flowchart of the patient selection for our study.
Supplementary AVS indices
As mentioned before, the AV/IVC index was calculated as the gradient 
of the ACR between AV and IVC to predict the laterality of PA. Accord-
ing to Pasternak, ipsilateral disease (lateralized aldosterone secretion 
from the ipsilateral side of the catheterized AV) was diagnosed if the 
LAV/IVC index was ≥ 5.5, and contralateral disease (lateralized aldo-
sterone secretion from the contralateral side of the catheterized AV) 
if the LAV/IVC index was ≤ 0.5 [16]. We examined whether data from 
incomplete AVS with presumed right-sided failure could accurately 
predict lateralization in the same way as in the initial study. An inap-
propriate adrenalectomy rate, defined as removing the wrong adrenal 
in lateralized PA or any surgery in bilateral PA, and failed lateralization 
rate, defined as missed lateralized PA, were also calculated, as previ-
ously suggested [17]. The recently published cut-offs of ≥ 2.42 for 
diagnosing ipsilateral disease and of ≤ 0.08 for diagnosing contralateral 
disease, which demonstrated perfect specificity in a comparable single-
centre report [18], were tested in our study cohort. 
In addition, the optimization of AV/IVC index cut-offs was attempt-
ed for our institution, where we also examined the less common 
scenario with presumed AVS failure on the left side by applying the 
RAV/IVC index. The utilized AVS indices are summarized in Table 1.
Assays
Serum aldosterone was measured using an Active® Aldosterone RIA 
(Beckman Coulter, Immunotech, Czech Republic). Serum cortisol 
which means additional costs and risks, or they are 
simply directed towards less optimal medical treatment 
[7]. Pasternak et al. have questioned this conventional 
approach by demonstrating that incomplete data from 
only left-sided AVS and IVC in the setting of failed 
cannulation of the RAV could correctly anticipate lat-
eralization. In their surgical series of 62 patients with 
lateralized PA the LAV/IVC index calculated as the gra-
dient of the cortisol-corrected aldosterone ratio (ACR) 
between LAV and IVC of ≥ 5.5 and ≤ 0.5 would forecast 
left- and right-sided disease, respectively, with a posi-
tive predictive value of 100% [16]. However, subsequent 
validations of the proposed model in other cohorts 
have recently disputed its original robust predictive 
utility because they yielded mixed and inconclusive 
results [17–19]. 
Primarily, we aimed to validate the diagnostic utility 
of the originally proposed LAV/IVC index [16] for PA 
subtyping in our sizeable cohort of surgical candidates 
who had successful AVS. Secondary objectives were 
to optimize the cut-offs of the same index for our in-
stitution and to test this clinical tool for the less likely 
scenario of LAV cannulation failure.
Material and methods
Study design
We conducted a retrospective cross-sectional study from November 
2004 to the end of 2019 at the Slovenian national tertiary endocrine 
referral centre. All the data were extracted from the Slovenian AVS 
database. The data collection and its analysis were approved by the 
National Medical Ethics Committee (ID 0120-216/2020/3).
Patients
All patients with confirmed PA, who underwent AVS at our centre 
during the study period, were candidates for enrolment. PA was 
diagnosed according to the existing Endocrine Society guidelines 
[11, 20], as previously detailed elsewhere [21]. Further inclusion 
criteria were bilaterally successful AVS and definite diagnosis of 
either lateralized or bilateral PA. The AVS-based term “lateralized” 
was preferred over unilateral due to recent data, which suggests 
that most cases of presumably unilateral PA may actually display 
mild aldosterone excess from the contralateral gland [22].
Adrenal imaging and AVS
All patients with confirmed PA underwent a thin-slice computed 
tomography (CT) scan (Siemens, Erlangen, Germany). Any thicken-
ing of 5 mm or more was considered abnormal. 
AVS preparation and technique have been reported previously 
[23]. In summary, AVS was performed in the morning between 8 
and 9 a.m. by two interventional radiologists. Continuous ACTH 
stimulation (50 μg/h) was initiated 30 min before sampling and 
continued throughout the procedure. AVS was performed sequen-
tially with the more challenging right adrenal vein always being 
cannulated and sampled first to keep the delay between the sides 
under 5 minutes in most of our AVS procedures [24]. When the 
selectivity index (SI), determined as the ratio of concentrations of 
cortisol from an adrenal vein and the infra-adrenal inferior vena 
cava (IVC), on both sides was at least 5, AVS was considered bilater-
ally successful. The lateralization index (LI) was calculated as the 
ratio of the higher over the lower cortisol-corrected aldosterone 
238 patients underwent AVS 
201 successful AVS 
37 patients unsuccessful AVS 
20 equivocal LI (3–4) 
7 LPA, refused operation 
4 operated, lost to follow-up 
2 not biochemically cured 
168 patients for analysis 
Figure 1. Flowchart demonstrating the patient selection 
for our study population. AVS — adrenal vein sampling; 
LI — lateralization index; LPA — lateralized primary aldosteronism
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was measured with an automated chemiluminescent immunoassay 
(CLIA) on a Immulite® 2000 XPi (Siemens Healthcare, Gwynedd, 
United Kingdom). The respective within- and between-assay co-
efficients of variation were below 4.5% and 9.8% for aldosterone 
and below 6.8% and 9.4% for cortisol, respectively. Plasma renin 
activity (PRA) was measured using an Angiotensin I RIA KIT 
(Beckman Coulter, Immunotech, Czech Republic). The respective 
within- and between-assay coefficients of variation were below 
11.3% and 20.9%, respectively.
Statistical analysis
Numerical variables were described as mean, SD, median, and 
range; categorical variables were presented as frequencies. The dif-
ferences in the characteristics between patients with lateralized and 
bilateral PA were tested using the t-test and exact Mann-Whitney 
test for numerical variables, and Fisher’s exact test for categorical 
variables. Receiver operating characteristic (ROC) curve analysis 
was used to determine the ability of a given marker to distinguish 
patients with lateralized from those with bilateral disease. The 
overall predictive value of a marker was assessed as the area under 
the ROC curve (AUC) with 95% confidence interval (CI). Optimal 
cut-off values were determined using either Youden’s index or 
desired specificity, and sensitivity and specificity associated with 
each cut-off was reported. The statistical significance level was set 
at p ≤ 0.05. Diagnostic accuracy was compared between LAV/IVC 
index-based and RAV/IVC index-based criteria using the exact 
McNemar test. Statistical analyses were conducted using IBM SPSS 
Statistics 25 (IBM Corp., Armonk, USA, 2017).
Results
Patient characteristics
A total of 238 patients underwent AVS during the study 
period (Fig. 1). The inclusion criteria were met in 168 
patients, 46 women and 122 men, aged 54 years on av-
erage (range 32–72 years); 67 with lateralized (30 right; 
37 left) and 101 with bilateral PA. Most of them had 
a unilateral adrenal nodule (56%; 21% right, 35% left) 
on CT scan, while bilateral adrenal abnormalities were 
present in 8% of the cases. The average tumour size 
was 16.4 ± 10.5 mm. Both adrenals were considered 
normal in 36% of cases. The main reason for work-up 
was hypertension with hypokalaemia (55%). Most of 
the remaining patients (39%) were referred due to re-
sistant hypertension and some (6%) due to an adrenal 
incidentaloma. Additional clinical characteristics and 
laboratory parameters of the study group are presented 
by disease subtype in Table 2. As expected, lateralized 
patients had more severe PA with significantly lower 
potassium values, and higher aldosterone concentra-
tions and aldosterone–renin ratios. There were no other 
meaningful differences in any other analysed clinical 
characteristics or laboratory parameters between the 
two groups.
AVS data
AVS results of the study group by final diagnosis are 
presented in Table 3. When compared to the bilateral 
group, the lateralized patients had higher aldosterone 
values in LAV and IVC, with a similar trend in RAV. 
Their LI values were also significantly higher, as antici-
pated. On the other hand, cortisol values in IVC were 
higher in bilateral patients. 
The mean LAV/IVC index was 6.20 (median 4.32; 
range 1.68–39.71) for patients with left lateralized PA, 
0.57 (0.51; 0.04–1.63) for patients with right lateralized 
PA, and 2.47 (2.22; 0.02–14.26) for the bilateral group. 
The mean RAV/IVC index was 9.02 (6.16; 1.14–72.70) for 
patients with right lateralized PA, 0.56 (0.40; 0.05–4.08) 
for patients with left lateralized PA, and 2.69 (2.31; 
0.03–19.19) for the bilateral group. Figure 2 shows 
a logarithmic-scale dot-density plot of the LAV/IVC 
index categorized by final diagnosis, while the RAV/IVC 
index is represented likewise in Figure 3. 
Prediction of lateralized disease 
LAV/IVC index by Pasternak’s cut-offs of ≥ 5.5 or ≤ 0.5 
anticipated left lateralized PA with a sensitivity of 32% 
and specificity of 97%, while a sensitivity of 47% and 
specificity of 95% were found for right lateralized PA 
in our cohort. The recently introduced cut-offs of ≥ 2.42 
or ≤ 0.08 by Suntornlohanakul performed even less 
optimally in our patients, both for ipsilateral and con-
tralateral disease, so no further analysis was attempted 
(Tab. 4). 
When using Pasternak’s cut-offs, the overall inap-
propriate adrenalectomy rate in our cohort was 29.7% 
(p = 0.314 for comparison between sides). When as-
Table 1. Adrenal vein sampling indices, definition, clinical significance, and cut-offs in the present study. Adapted from [11, 15, 16]
Measurement Clinical significance Cut-off
Selectivity index (SI) Cortisol AV/cortisol IVC Adequacy of cannulation of the AV > 5
Lateralization index (LI) (Aldosterone/cortisol) dominant AV / /(aldosterone/cortisol contralateral AV )
Differentiation between lateralized 
and bilateral PA
> 4: lateralized PA
< 3: bilateral PA
3–4: equivocal result (the grey zone)
AV/IVC index (Aldosterone/cortisol) available AV //(aldosterone/cortisol) IVC
Prediction of lateralization  
in the setting of unilateral AV 
cannulation failure
≥ 5.5: ipsilateral lateralized PA
≤ 0.5 contralateral lateralized PA
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certaining ipsilateral disease (LAV/IVC index ≥ 5.5), 4 
out of 16 patients (25%) would have been incorrectly 
sent to left adrenalectomy. Inappropriate right adre-
nalectomy would have occurred in 7 out of 21 patients 
(33.3%) if a LAV/IVC index of ≤ 0.5 had been used to 
predict contralateral disease. Thus, 11 patients with 
bilateral PA (6.5% of the entire cohort) would have been 
misclassified as lateralized PA and referred to surgery. 
Failed lateralization would have occurred in 61.2% of 
patients overall; this rate was 53.3% for overlooked 
contralateral disease and 67.6% for missed ipsilateral 
disease (p = 0.723 for comparison between sides).
Ninety-three patients (55.3%) had a unilateral 
adrenal nodule on CT. If just the CT results had been 
considered, the inappropriate adrenalectomy rate 
would have been 46.2% overall. An adrenal gland on 
the wrong side would have been removed in one case, 
while all other patients were diagnosed with bilateral 
PA by AVS. On the other hand, according to CT, 19.4% of 
our patients would have failed to lateralize and would 
not have been offered the curative surgery.
The optimization of AV/IVC index cut-offs for our 
institution was done by ROC analysis. Both failed right 
and failed left adrenal vein cannulation were hypoth-
esized. The AUCs were in the range 0.87–0.95, which 
indicates a good predictive ability. Optimal cut-offs 
according to the Youden index are shown in Table 5. 
Controlling specificity at 95%, the highest possible 
Table 2. Clinical characteristics and laboratory parameters of the patients by final diagnosis
Characteristic Lateralized Bilateral pt, pM-W, or pFET
Age [years] 52.9 (54.0) [34–70] 55.1 (55.0) [32–72] 0.105; 0.118
BMI [kg/m2] 30.0 (30.4) [18–45] 31.1 (30.3) [21–48] 0.173; 0.255
Potassium (lowest value) 3.3 (3.4) [2–4] 3.7 (3.7) [3–5] < 0.001; 0.000
Creatinine [µmol/L] 78.1 (74.0) [33–165] 81.8 (78.0) [42–181] 0.305; 0.333
eGFR* [mL/min] 90.4 (90.0) [36–132] 86.4 (89.0) [34–122] 0.196; 0.160
DDD 4.9 (5.0) [0–10] 4.7 (4.0) [0–12] 0.620; 0.450
Systolic BP [mm Hg] 159 (155) [129–210] 157 (157) [100–213] 0.525; 0.722
Diastolic BP [mm Hg] 91 (90) [65–120] 88 (90) [61–132] 0.148; 0.142
Aldosterone [pmol/L] 1234 (981) [210–8760] 768 (702) [240–2010] 0.002; 0.001
Plasma Renin Activity (PRA)** 0.2 (0.2) [0.2–1.0] 0.2 (0.2) [0.2–0.9] 0.455; 0.128
Aldosterone-renin ratio (ARR) 8898 (5150) [1050–52000] 3565 (2900) [1200–18000] < 0.001; 0.000
Tumour size [mm] 16.9 (16.0) [5–30] 15.9 (11.5) [5–43] 0.640; 0.077
Sex (female / male) 30%/70% 26%/74% 0.598
Reason for work-up*** 64%/3%/33% 48%/8%/44% 0.110
BMI — body mass index; eGFR — estimated glomerular filtration rate; DDD — defined daily dose; BP — blood pressure. Descriptive statistics are reported as mean 
(median) [range] for numeric variables and number (percentage) for categorical variables; pt — from independent-samples t-test for numeric variables; pM-W — from 
exact Mann-Whitney test for numeric variables; pFET — from Fisher’s exact test for categorical variables; *CKD EPI; **the lowest PRA value that was used for the 
statistical analysis was set at a minimum of 0.2 ng/mL/h, in order to avoid overinflating ARR [14]; *** hypokalaemia (and hypertension)/adrenal tumour/hypertension 
only; characteristics with pt or pM-W  < 0.05 are shaded in grey
Table 3. Adrenal vein sampling parameters of the patients by final diagnosis 
AVS parameter Lateralized Bilateral pt, pM-W
Aldosterone in RAV [pmol/L] 190822 (36800) [116–2537000] 106186 (76550) [1640–385600] 0.070; 0.137
Cortisol in RAV [nmol/L] 21873 (19561) [566–78990] 23532 (22596) [5380–62767] 0.371; 0.267
Aldosterone in LAV [pmol/L] 181588 (71600) [34–1570000] 95171 (86700) [720–302000] 0.006; 0.637
Cortisol in LAV [nmol/L] 21405 (20003) [924–67347] 23541 (23148) [4828–64754] 0.197; 0.078
Aldosterone in IVC [pmol/L] 2587 (2310) [300–10680] 1930 (1730) [310–8980] 0.009; 0.005
Cortisol in IVC [nmol/L] 847 (877) [95–1255] 988 (927) [571–2607] 0.001; 0.009
Selectivity index — RAV 25.7 (23.6) [5–88] 24.5 (23.6) [6–53] 0.555; 0.945
Selectivity index — LAV 25.0 (22.9) [6–75] 24.5 (23.7) [5–51] 0.753; 0.968
Lateralization index 24.4 (11.1) [4–371] 1.7 (1.5) [1–3] < 0.001; 0.000
RAV — right adrenal vein; LAV — left adrenal vein; IVC — inferior vena cava. Descriptive statistics are reported as mean (median) [range] for numeric variables;  
pt — from independent-samples t-test; pM-W — from exact Mann-Whitney test; parameters with pt or pM-W < 0.05 are shaded in grey
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sensitivity was 51%, with a LAV/IVC index of ≥ 4.3 to 
predict left lateralized PA. To attain a specificity of 99%, 
at a LAV/IVC index of ≥ 5.9, the sensitivity would de-
crease to 30%. On the other hand, a specificity of 95% 
would lead to a sensitivity of 57%, with a LAV/IVC index 
of ≤ 0.54 to predict right lateralized disease. Almost 
perfect specificity of 99%, at a LAV/IVC index of ≤ 0.28, 
would reduce the sensitivity to 40%. 
Correspondingly, with a specificity of 95%, the high-
est attainable sensitivity was 67%, with a RAV/IVC index 
of ≥ 5.1 to predict right lateralized PA, while increasing 
specificity to 99% at a RAV/IVC index of ≥ 7.5 would 
decrease sensitivity to 33%. Controlling specificity at 
95%, the highest possible sensitivity was 87%, with 
a RAV/IVC index of ≤ 0.69 to predict left lateralized 
disease. To achieve a specificity of 99%, at a RAV/IVC 
index of ≤ 0.06, the sensitivity would drop to 3%.
Diagnostic accuracy did not differ statistically sig-
nificantly between LAV/IVC index-based (for which it 
was 82.7%) and RAV/IVC-index based prediction (for 
which it was 86.3%; p = 0.448). 
Discussion
The present study does not support utilizing LAV/IVC 
index cut-offs of ≥ 5.5 and ≤ 0.5 in the setting of failed 
right AV cannulation during AVS to predict lateralized 
















Figure 3. Logarithmic-scale dot-density plot of the right adrenal 
vein and inferior vena cava (RAV/IVC) index, calculated as the 
gradient of the cortisol-corrected aldosterone ratio (ACR) between 
RAV and IVC, categorized by final diagnosis [right lateralized 
primary aldosteronism (PA), left lateralized PA, bilateral PA]; 















Figure 2. Logarithmic-scale dot-density plot of the left adrenal 
vein and inferior vena cava (LAV/IVC) index, calculated as the 
gradient of the cortisol–corrected aldosterone ratio (ACR) between 
LAV and IVC, categorized by final diagnosis [right lateralized 
primary aldosteronism (PA), left lateralized PA, bilateral PA]; 
AVS — adrenal vein sampling
Table 4. Measures of diagnostic validity of the Pasternak et al. [16] and Suntornlohanakul et al. [18] criteria for our sample 
utilizing LAV/IVC index to predict ipsilateral or contralateral disease without data from the right adrenal vein
Authors Disease LAV/IVC index Sensitivity (%) Specificity (%) PPV NPV
Pasternak et al.
Ipsilateral ≥ 5.5 32 97 0.75 0.84
Contralateral ≤ 0.5 47 95 0.67 0.89
Suntornlohanakul et al.
Ipsilateral ≥ 2.42 89 64 0.41 0.96
Contralateral ≤ 0.08 10 99 0.75 0.84
LAV — left adrenal vein; IVC — inferior vena cava; PPV — positive predictive value; NPV — negative predictive value
Table 5. Summary of receiver operating characteristic (ROC) analyses of our data
Prediction from Prediction of AUC (95% CI)* Optimal cut-off Sensitivity (%)** Specificity (%)**
LAV/IVC index Left unilateral disease 0.87 (0.81–0.93) > 2.50 87 70
LAV/IVC index Right unilateral disease 0.95 (0.91–0.98) < 1.25 97 87
RAV/IVC index Right unilateral disease 0.89 (0.81–0.97) > 3.90 77 89
RAV/IVC index Left unilateral disease 0.94 (0.89–0.98) < 0.85 89 92
AUC — area under ROC-curve; CI — confidence interval; LAV — left adrenal vein; IVC — inferior vena cava; RAV — right adrenal vein; *all p-values for the null 
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et al. [16]. With that approach, the overall inappropriate 
adrenalectomy rate in our cohort would be 29.7%. Con-
sequently, 11 of 168 patients (6.5%) would have been 
incorrectly sent to surgery. Wang et al. have recently 
reported likewise that 11% of their 222 patients would 
have had inappropriate adrenalectomy when selected 
for surgery by the same clinical tool [19]. Another vali-
dation study by Strajina et al. managed to prove the 
original positive predictive value of 100% for contralat-
eral disease, but failed to show the same for ipsilateral 
disease, where the overall inappropriate adrenalectomy 
rate remained high at 18% [17]. Interestingly, we found 
no difference in predictive power for either side. Fur-
thermore, no LAV/IVC index could correctly predict 
laterality in our cohort with a clinically acceptable level 
of sensitivity, which is in concordance with previously 
published data [19]. Contrary to the original study, we 
also tested the RAV/IVC index to predict lateralized 
disease in the less likely scenario of failed LAV can-
nulation and found similarly inadequate diagnostic 
performance. On the other hand, a small single-centre 
study by Suntornlohanakul et al. recently found the 
Pasternak’s cut-offs as highly indicative for lateralized 
PA, both for ipsilateral and especially for contralateral 
disease [18]. However, as noted also by the authors 
themselves, their study cohort was rather unusual 
because it included predominantly female patients 
(77%) with biochemically severe PA and hypokalaemia 
in 90% of the cases. Unsurprisingly, 85% of this group 
had lateralized disease by AVS, which was comparable 
to Pasternak’s original cohort with 73% of lateralized 
patients [16, 18]. In contrast, our group consisted of 
mostly male patients (72%) with less severe PA, less 
frequent hypokalaemia (55%), and predominantly bi-
lateral disease (60%). Notably, patients with the above-
mentioned clinical characteristics closely resemble the 
usual contemporary referrals for AVS, as shown by the 
recent international AVIS-2 study, which included 1625 
patients with PA subtyped by AVS [26]. Similarly, both 
previously mentioned studies, which also failed to fully 
confirm the premise by Pasternak, included only about 
half of lateralized patients [17, 19]. Thus, the original 
cut-offs do not seem to be entirely relevant in settings 
where patients’ characteristics or the disease-pattern 
differ from the original surgical cohort of patients with 
severe PA, who predominantly lateralized by AVS. 
Inferior performance of the optimized cut-offs for the 
Suntornlohanakul cohort [18], when tested to predict 
lateralization in our patients, further confirmed this as-
sumption. Additionally, it is not possible to exclude the 
impact of different assay methods for aldosterone and 
cortisol on the diagnostic utility of the indices derived 
from partial AVS data. Ideally, referral centres should 
validate or appropriately adjust the published values to 
their local circumstances. Because there is no universal 
protocol for AVS, special care should be taken in centres 
that might use non-stimulated AVS. Indeed, it has been 
shown that the original cut-offs perform poorly and 
are not applicable to unstimulated AVS studies [27]. 
This finding may result from less frequent contralateral 
suppression, which was shown to be present in 62–76% 
of lateralized PA in non-stimulated AVS studies, and in 
89–93% in stimulated ones [28].
If Pasternak’s cut-offs were used for clinical deci-
sion making, all inappropriate adrenalectomies in our 
cohort would have occurred due to misclassification of 
patients with bilateral PA as lateralized PA. Although 
noncurative unilateral adrenalectomy should not be en-
tirely dismissed as a treatment option for some patients 
with bilateral disease [7], optimal management of PA 
still critically depends on realizing whether the excess 
of aldosterone is secreted from one or both adrenal 
glands. This is essential not only to avoid inappropriate 
surgery, but also to enable many patients with lateral-
ized disease to avoid lifelong medical treatment and 
considerably benefit from curative adrenalectomy [6, 
11]. Importantly, by using Pasternak’s criteria, failed 
lateralization would have occurred in 61.2% of our 
patients overall. 
Adrenal CT scan is recommended as the first test 
in the subtype evaluation of PA by the guidelines [11]; 
however, according to a systematic review on 950 
patients, it might have missed the type of PA in 37.8% 
of cases [29], which is similar to the present study. 
Consequently, AVS remains the only reliable method 
for subtype diagnosis, which is recommended before 
adrenal surgery in all patients with PA, apart from 
infrequent patients under 35 years of age with severe 
disease and unilateral abnormality on CT, who could 
probably proceed directly to surgery [30]. Therefore, 
every effort should be given to improve the AVS suc-
cess rate. The procedure should follow a well-defined 
protocol, and it should be performed by a dedicated 
radiologist with higher workload [13, 23, 31]. Stimulated 
AVS maximizes the selectivity index, so it might be more 
suitable for less experienced and low-volume centres 
[15,31]. Difficulty of cannulating the RAV could be at 
least partially overcome by intra-procedural cone beam 
CT [23,32] and other technical developments, such as 
ultra-rapid on-site measurement of the cortisol level in 
adrenal veins [33]. 
Limitations of the present study include its retro-
spective design, which might have caused a patient 
selection bias. However, all important clinical and 
laboratory data were registered in our AVS database, 
almost without missing values. An additional potential 
source of error is the unknown autonomous cortisol 
co-secretion in some patients, because dexamethasone 
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suppression testing was initially not done routinely, but 
only in selected patients according to the guidelines 
[11]. Fortunately, this phenomenon seems to have only 
a limited impact on stimulated AVS parameters [34]. 
Broader applicability of the results is also questionable 
due to centre-specific laboratory assays and stimulated 
AVS protocol. Notably, selective cannulation of the LAV 
by a microcatheter instead of blood sampling from the 
common trunk of the inferior phrenic vein and the LAV 
was done in most of our cases [23], which might have 
influenced our AVS indices. Additionally, some of the 
patients who were diagnosed with bilateral disease 
might in fact have had lateralized disease, because 
there is no actual reference for the diagnosis of bilateral 
PA, which is an inherent problem in all similar studies.
On the other hand, our study relies on the PASO 
criteria for post-adrenalectomy biochemical cure as the 
gold standard for lateralized PA [6], which was not the 
case in all other similar reports [16–19]. Furthermore, 
our patients with ambiguous lateralization index be-
tween 3 and 4 were excluded from the analysis. Finally, 
our results are based on a considerable cohort of typical 
patients with PA [26], who were managed in a standard-
ized way and according to the Endocrine Society clinical 
guidelines when achievable [11, 20].
Conclusions
Based on the present study, we conclude that the ap-
plication of the suggested LAV/IVC index cut-offs did 
not predict lateralized PA with the high accuracy pre-
viously reported. Moreover, according to our analysis, 
no AV/IVC index was precise enough for reliable PA 
subtyping. Bilaterally successful AVS remains the gold 
standard for this purpose, so maximum effort should be 
employed to improve local performance of the method.
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